Mathilde C M Kouwenhoven
Overview
Explore the profile of Mathilde C M Kouwenhoven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Garderen K, Vallentgoed W, Lavrova A, Niers J, de Leng W, Hoogstrate Y, et al.
Neurooncol Adv
. 2023 Nov;
5(1):vdad149.
PMID: 38024241
Background: The T2-FLAIR mismatch sign is defined by signal loss of the T2-weighted hyperintense area with Fluid-Attenuated Inversion Recovery (FLAIR) on magnetic resonance imaging, causing a hypointense region on FLAIR....
12.
van der Meer D, Zevenbergen S, Vlooswijk C, Bijlsma R, Kaal S, Kerst J, et al.
Oncologist
. 2023 Nov;
29(4):e526-e534.
PMID: 37995309
Background: Adolescent and young adult cancer survivors (AYAs, aged 18-39 years at first diagnosis) have a higher second cancer risk. Accelerated aging is hypothesized as underlying mechanism and has been...
13.
van der Meer P, Dirven L, Fiocco M, Vos M, Kerkhof M, Kouwenhoven M, et al.
J Neurooncol
. 2023 Sep;
164(3):545-555.
PMID: 37755633
Background: Withdrawal of antiseizure medication treatment (ASM) can be considered after completion of antitumour treatment in glioma patients who no longer suffer from seizures. We compared the risk for recurrent...
14.
Vlooswijk C, Janssen S, van de Poll-Franse L, Bijlsma R, Kaal S, Kerst J, et al.
J Patient Rep Outcomes
. 2023 Sep;
7(1):93.
PMID: 37702884
The health-related quality of life (HRQoL) among long-term Adolescent and Young Adult Cancer Survivors (AYACS) and an age- and sex-matched normative population was examined. Although the HRQoL of AYACS was...
15.
Janssen S, Vlooswijk C, Manten-Horst E, Sleeman S, Bijlsma R, Kaal S, et al.
Cancer Med
. 2023 Apr;
12(12):13712-13731.
PMID: 37119039
Background: Despite growing (inter)national awareness and appreciation, age-specific care is still not always self-evident and accepted as standard of care for adolescent and young adult (AYA) cancer patients. It is...
16.
van Lingen M, Breedt L, Geurts J, Hillebrand A, Klein M, Kouwenhoven M, et al.
Brain Imaging Behav
. 2023 Apr;
17(4):425-435.
PMID: 37067658
Many patients with glioma, primary brain tumors, suffer from poorly understood executive functioning deficits before and/or after tumor resection. We aimed to test whether frontoparietal network centrality of multilayer networks,...
17.
Said M, Broen M, Swart E, Bartelink I, Kouwenhoven M
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900352
Glioblastoma multiforme is the most common primary central nervous system tumor, with an incidence of 3 [...].
18.
Rottgering J, Belgers V, Kouwenhoven M, Schuur M, Postma T, Nijboer C, et al.
Heliyon
. 2023 Feb;
9(2):e13278.
PMID: 36798771
Background & Aims: Glioma patients experience a multitude of symptoms that negatively affect their health-related quality of life. Symptoms vary greatly across disease phases, and the patients' stable phase might...
19.
van der Meer P, Dirven L, Fiocco M, Vos M, Kouwenhoven M, van den Bent M, et al.
Neurology
. 2023 Feb;
100(14):e1488-e1496.
PMID: 36754633
Background And Objectives: Approximately 10% of patients with glioma with epilepsy need antiseizure medication (ASM) triple therapy due to refractory epilepsy. The aim of this study was to evaluate whether...
20.
Saris L, Vlooswijk C, Kaal S, Nuver J, Bijlsma R, van der Hulle T, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358662
Adolescent and young adult (AYA) cancer survivors (18-39 years at diagnosis) often experience negative body changes such as scars, amputation, and disfigurement. Understanding which factors influence body image among AYA...